Abstract 2386: High-throughput assessment of the VEGFR2 kinase activity profile in pediatric brain tumor tissue
Arend H. Sikkema, Wilfred F. den Dunnen(University Medical Center Groningen), Grietje Molema(University Medical Center Groningen), Peter J. Zwiers(University Medical Center Groningen), Eelco W. Hoving(Princess Máxima Center), Maikel P. Peppelenbosch(Erasmus MC), Eveline S. de Bont(Radboud University Nijmegen), Anna Dimberg(Uppsala University), Willem A. Kamps(Pediatric Oncology Group), Sander H. Diks
Cited by 1
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Consensus guidelines for the use and interpretation of angiogenesis assays
|Angiogenesis|2018|602
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599